Celcuity (CELC) Is Down 17.4% After FDA Clears First-in-Class REVTORPYK Combo for HR+ Breast Cancer
Celcuity (CELC) Is Down 17.4% After FDA Clears First-in-Class REVTORPYK Combo for HR+ Breast Cancer simplywall.st
Regulatory Approvals
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape?
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape? HCP Live
Takeda wins approval for first Dengue vaccine in India
Takeda wins approval for first Dengue vaccine in India medwatch.com
FDA clears combined patient warming, securement device for robotic surgery
FDA clears combined patient warming, securement device for robotic surgery Medical Economics
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD HCP Live